UnitedHealth Group (NYSE:UNH) Upgraded to “Hold” at HSBC

HSBC upgraded shares of UnitedHealth Group (NYSE:UNH) from a reduce rating to a hold rating in a report published on Tuesday morning, Marketbeat Ratings reports. HSBC currently has $300.00 price objective on the healthcare conglomerate’s stock.

A number of other equities research analysts also recently commented on the company. Truist Financial decreased their target price on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a report on Monday, February 2nd. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a research report on Friday, January 30th. Finally, Mizuho decreased their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $363.42.

UnitedHealth Group Trading Up 9.3%

NYSE:UNH opened at $307.55 on Tuesday. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $606.36. The firm has a fifty day simple moving average of $282.12 and a 200-day simple moving average of $319.04. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $279.16 billion, a P/E ratio of 23.32, a PEG ratio of 1.28 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the firm posted $6.81 earnings per share. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group’s dividend payout ratio is 67.02%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. J. Derek Lewis & Associates Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $508,000. Purpose Unlimited Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $32,374,000. Cornerstone Planning LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $2,295,000. Rockefeller Capital Management L.P. raised its position in shares of UnitedHealth Group by 8.9% during the 4th quarter. Rockefeller Capital Management L.P. now owns 320,574 shares of the healthcare conglomerate’s stock worth $105,825,000 after purchasing an additional 26,328 shares during the last quarter. Finally, Winthrop Partners WNY LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $613,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalized a larger-than-expected 2027 Medicare Advantage payment increase (net average +2.48%), meaningfully above January’s proposal and street expectations — the decision injects roughly $13B+ into the MA program and is the main catalyst for today’s rally. Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
• Positive Sentiment: Brokerages moved to capitalize on the policy tailwind: Sanford C. Bernstein and others raised price targets and ratings, and Bank of America boosted its PT — analyst upward revisions help sustain the rally by signaling higher modeled earnings and margin recovery. Sanford C. Bernstein price target update
• Positive Sentiment: Sector-wide lift — other insurers (Humana, Centene, Oscar Health) rose on the same CMS decision, reinforcing that UnitedHealth benefits from industry-level tailwinds (scale and MA exposure). UnitedHealth and other insurer stocks jump after Medicare agrees to lift payments next year
• Neutral Sentiment: Macro/market context is mixed — broader US indexes showed mixed action Tuesday (oil lower, geopolitics impacting sentiment), so some of UNH’s move is idiosyncratic to healthcare rather than a broad market rally. US Equity Markets Mixed Amid Lower Crude Oil Price, Diminishing Hopes of Iran Ceasefire Deal
• Negative Sentiment: Risks remain — elevated medical cost pressures, previous guidance weakness and an upcoming Q1 report (April 21) could reintroduce volatility if results or forward commentary disappoint; the policy boost reduces but does not eliminate these operational risks. UnitedHealth Q1 Earnings Preview

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.